In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake

Authors

  • Brittany K. Gorres,

    1. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, MS 3043, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Search for more papers by this author
  • Gregory L. Bomhoff,

    1. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, MS 3043, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Search for more papers by this author
  • Jill K. Morris,

    1. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, MS 3043, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Search for more papers by this author
  • Paige C. Geiger

    1. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, MS 3043, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Search for more papers by this author

Corresponding author P. C. Geiger: Department of Molecular and Integrative Physiology, University of Kansas Medical Center, MS 3043, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.  Email: pgeiger@kumc.edu

Abstract

Non-technical summary  Previous studies show that oestrogen is beneficial for maintaining blood glucose levels and helping the body respond to insulin. Despite these previous findings, the mechanism by which oestrogen acts is unknown. We show that specific activation of oestrogen receptor α (ERα) increases glucose uptake into skeletal muscle when insulin is present. Activation of oestrogen receptor β (ERβ) alone or activation of both ERα and ERβ together did not increase glucose uptake into skeletal muscle. This suggests that oestrogen's beneficial effect occurs by activating ERα. These results have important implications for understanding the mechanisms of glucose homeostasis, particularly in postmenopausal women with low oestrogen levels.

Abstract

Abstract  Previous studies suggest oestrogen receptor α (ERα) is involved in oestrogen-mediated regulation of glucose metabolism and is critical for maintenance of whole body insulin action. Despite this, the effect of direct ERα modulation in insulin-responsive tissues is unknown. The purpose of the current study was to determine the impact of ERα activation, using the ER subtype-selective ligand propylpyrazoletriyl (PPT), on skeletal muscle glucose uptake. Two-month-old female Sprague–Dawley rats, ovariectomized for 1 week, were given subcutaneous injections of PPT (10 mg kg−1), oestradiol benzoate (EB; 20 μg kg−1), the ERβ agonist diarylpropionitrile (DPN, 10 mg kg−1) or vehicle every 24 h for 3 days. On the fourth day, insulin-stimulated skeletal muscle glucose uptake was measured in vitro and insulin signalling intermediates were assessed via Western blotting. Activation of ERα with PPT resulted in increased insulin-stimulated glucose uptake into the slow-twitch soleus and fast-twitch extensor digitorum longus (EDL) muscles, activation of insulin signalling intermediates (as measured by phospho-Akt (pAkt) and pAkt substrate (PAS)) and phosphorylation of AMP-activated protein kinase (AMPK). GLUT4 protein was increased only in the EDL muscle. Rats treated with EB or DPN for 3 days did not show an increase in insulin-stimulated skeletal muscle glucose uptake compared to vehicle-treated animals. These new findings reveal that direct activation of ERα positively mediates glucose uptake and insulin action in skeletal muscle. Evidence that oestrogens and ERα stimulate glucose uptake has important implications for understanding mechanisms of glucose homeostasis, particularly in postmenopausal women.

Ancillary